March 2021 Reports
The 31-day standard states that 95% of all patients should wait no more than 31 days from decision to treat to first cancer treatment. 98.6% of patients started treatment within the 31-day standard, compared with 98.4% in the previous quarter and 96.5% for quarter ending September 2019.
The 62-day standard states that 95% of eligible patients should wait a maximum of 62 days from urgent suspicion of cancer referral to first cancer treatment. 86.2% of patients started treatment within the 62-day standard, compared to 87.3% in the previous quarter, and 83.7% for quarter ending December 2019.
The 31 day target (of 96% of patients starting their first treatment within 31 days of diagnosis) was missed for cancer overall (94.0%) and was missed for breast cancer (93.9%). This is a decrease from 95.6% in January 2020, and 97.5% in December 2020. The total numbers in breast cancer have decreased from 4,194 in January 2020 to 3,491 in January 2021. Numbers in breast cancer also decreased from 4,012 in December 2020.
The 62 day target (of 85% of patients starting treatment within 62 days of urgent GP referral) was missed for cancer overall (71.2%) and was missed for breast cancer (79.8%). This is a decrease from 86.6% in January 2020 and 84.5% in December 2020. The total numbers have decreased from 1,990 in January 2020 to 1,958 in January 2021. The total numbers also decreased from 2,355 in December 2020.
62-day target met in 86.2% of cases in Scotland but only in 71.2% in England. 15 point difference is 21% better.